204 related articles for article (PubMed ID: 33058495)
1. Outcomes following repeat exenteration for locally advanced pelvic malignancy.
Blake J; Koh CE; Steffens D; De Robles MS; Brown K; Lee P; Austin K; Solomon MJ
Colorectal Dis; 2021 Mar; 23(3):646-652. PubMed ID: 33058495
[TBL] [Abstract][Full Text] [Related]
2. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
PelvExCollaborative
Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
[TBL] [Abstract][Full Text] [Related]
3. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer.
van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ
Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer.
Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ
Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111
[TBL] [Abstract][Full Text] [Related]
5. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
Williams M; Perera M; Nouhaud FX; Coughlin G
Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
[TBL] [Abstract][Full Text] [Related]
6. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A
Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392
[TBL] [Abstract][Full Text] [Related]
7. The Price We Pay for Radical Curative Pelvic Exenterations: Prevalence and Management of Pain.
Lim JS; Koh CE; Liu H; Solomon MJ; Johnstone CSH
Dis Colon Rectum; 2018 Mar; 61(3):314-319. PubMed ID: 29420427
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration.
Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA
Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305
[TBL] [Abstract][Full Text] [Related]
9. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
Xin KY; Ng DW; Tan GH; Teo MC
J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
[TBL] [Abstract][Full Text] [Related]
10. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series.
Lee PJ; Meshkat B; Sasidharan P; Zahid A; Coker DJ; Solomon MJ
ANZ J Surg; 2022 May; 92(5):1038-1043. PubMed ID: 34661958
[TBL] [Abstract][Full Text] [Related]
11. Minimally invasive versus open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes.
Kazi M; Kumar NAN; Rohila J; Sukumar V; Engineer R; Ankathi S; Desouza A; Saklani A
BJS Open; 2021 Sep; 5(5):. PubMed ID: 34518872
[TBL] [Abstract][Full Text] [Related]
12. [Results of laparoscopic pelvic exenterations].
Sanzharov AE; Gallyamov EA; Sergeev VP; Biktimirov RG; Aminova LN; Kochkin AD; Meshchankin IV; Agapov MA; Gololobov GY
Khirurgiia (Mosk); 2022; (7):45-57. PubMed ID: 35775844
[TBL] [Abstract][Full Text] [Related]
13. Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure?: a single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 2010.
Ghouti L; Pereira P; Filleron T; Humeau M; Guimbaud R; Selves J; Carrere N
Am J Surg; 2015 Feb; 209(2):352-62. PubMed ID: 25524284
[TBL] [Abstract][Full Text] [Related]
14. Curative pelvic exenteration: initial experience and clinical outcome.
Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
[TBL] [Abstract][Full Text] [Related]
15. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity.
Venchiarutti RL; Solomon MJ; Koh CE; Young JM; Steffens D
Br J Surg; 2019 Sep; 106(10):1393-1403. PubMed ID: 31282571
[TBL] [Abstract][Full Text] [Related]
16. Surgical, survival and quality of life outcomes in over 1000 pelvic exenterations: lessons learned from a large Australian case series.
Steffens D; Solomon MJ; Lee P; Austin K; Koh C; Byrne C; Karunaratne S; Hatcher S; Taylor K; McBride K
ANZ J Surg; 2023 May; 93(5):1232-1241. PubMed ID: 36869215
[TBL] [Abstract][Full Text] [Related]
17. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
Jäger L; Nilsson PJ; Rådestad AF
Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
[TBL] [Abstract][Full Text] [Related]
18. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
[TBL] [Abstract][Full Text] [Related]
19. Pelvic exenteration for chronic fistulating pelvic sepsis after multimodal treatment of pelvic malignancy.
Brown KGM; Risbey C; Solomon MJ; Austin KKS; Lee PJ; Byrne CM
Eur J Surg Oncol; 2023 Dec; 49(12):107124. PubMed ID: 37879161
[TBL] [Abstract][Full Text] [Related]
20. Retrospective review of pelvic malignancies undergoing total pelvic exenteration.
Kuhrt MP; Chokshi RJ; Arrese D; Martin EW
World J Surg Oncol; 2012 Jun; 10():110. PubMed ID: 22703863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
